Prof Mboyo-Di-Tamba Vangu

Mboyo-Di-Tamba Vangu is a nuclear medicine specialist and academic researcher whose work spans oncologic imaging, therapeutic dosimetry, and pulmonary disease. Affiliated with institutions in Southern Africa, his scholarship bridges clinical service and translational research, with strong engagement in global health collaborations. His contributions reflect a commitment to advancing imaging standards and improving diagnostic and therapeutic strategies in resource-constrained settings.

A central focus of his research is molecular imaging in lung disease and cancer, particularly the application of [18F]FDG PET/CT for therapy response assessment in lung cancer and tuberculosis. His work integrates radiologic, functional, and biomarker-based approaches, linking imaging findings with inflammatory markers and lung function outcomes in TB/HIV cohorts. He has also examined clinician interpretation of ventilation–perfusion imaging and optimized diagnostic pathways for pulmonary embolism.

Another key contribution lies in therapeutic nuclear medicine dosimetry, including development and validation of the Masterdose software for personalized radionuclide therapy planning. Through methodological innovation and comparative validation studies, his research strengthens quantitative imaging and absorbed dose assessment. Broader collaborations in kidney function measurement and host-directed TB therapies further highlight interdisciplinary expertise and a sustained impact on imaging-driven clinical decision-making.